Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Marginal Zone Lymphoma, Splenic MZL

Felix Drudi

MD

🏢University Hospital of Modena🌐Italy

Attending Hematologist

18
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Felix Drudi investigates splenic marginal zone lymphoma, a rare B-cell lymphoma often associated with hepatitis C virus, examining outcomes following splenectomy, rituximab monotherapy, and antiviral therapy in HCV-positive cases. His clinical research has contributed to understanding the natural history and optimal management of SMZL. He participates in the Italian network for rare lymphoma.

Share:

🧪Research Fields 研究领域

splenic marginal zone lymphoma
splenectomy lymphoma
hepatitis C lymphoma
SMZL rituximab
spleen irradiation

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Felix Drudi 的研究动态

Follow Felix Drudi's research updates

留下邮箱,当我们发布与 Felix Drudi(University Hospital of Modena)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment